John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 10,000 shares at $31.75 ($312K) on 2016-08-01, disclosed to the SEC on 2016-08-03.
Scheduled sale ($312k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.88 | 6,394 | $197K | 63.3% |
| 2 | $31.75 | 3,574 | $113K | 36.4% |
| 3 | $32.54 | 32 | $1K | 0.3% |
| Total | $31.20 avg | 10,000 | $312K | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |